Abacavir Sulfate : Latest News on Abacavir Sulfate , Abacavir Sulfate Updates, Abacavir Sulfate Videos, Photos, Wiki, Topic

Share >

Share on Tumblr

Abacavir Sulfate

News »
latest by relevance

Stride Arcolab gets tentative USFDA nod

May 17, 2010 at 14:43 | Source: Reuters

Strides Arcolab has received tentative US FDA approval for its generic drug abacavir sulfate in tablet form, the drug regulator's website showed on Monday.

Aurobindo gets approval for Abacavir Sulfate/Lamivudine tab

Dec 22, 2008 at 13:33

Aurobindo Pharma Limited is pleased to announce that it has received the tentative approval to manufacture and market fixed dosed combination Abacavir Sulfate / Lamivudine Tablets 60/30mg from the US Food & Drug Administration

Aurobindo Pharma gets approval for Abacavir Sulfate tabs

Sep 17, 2008 at 11:51

Aurobindo Pharma Limited is pleased to announce that it has received the tentative approval to manufacture and market Abacavir Sulfate tablets 60mg from the US Food & Drug Administration

Aurobindo gets approval for Abacavir Sulfate/Lamivudine tab

Sep 08, 2008 at 16:01

Aurobindo Pharma Limited is pleased to announce that it has received the tentative approval to manufacture and market Abacavir Sulfate / Lamivudine tablets 600mg/300mg from the US Food & Drug Administration

Aurobindo receives approval for Abacavir Sulfate solution

Jun 29, 2006 at 11:09

Aurobindo receives US FDA approval for Abacavir Sulfate solution. Yet another first generic version approval for Aurobindo Pharma

Photos »

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window

Explore Moneycontrol

STOCKS A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others

MUTUAL FUNDS A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.